Innoviva Q4 2021 royalties up 18% to $111.1M; announces $45M strategic investment in Armata

Innoviva, Inc.

2021-FY EPS reported $2.87 revenue$391,866,000

Gross royalty revenues $111.1M in Q4 2021 (+18% YoY); full year 2021 $405.7M (+19%).
Income from operations $104.5M (+23% YoY); diluted EPS $2.87 (+40%).
Invested $4M in Armata in Q4 2021 and additional $45M in Feb 2022, expected to own ~70%.
TRELEGY global net sales up 53% to $480.2M; ANORO down 17%; RELVAR/BREO up 3%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.